Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 242, Issue 1, 1998, Pages 202-208

  Peifley, Kimberly A ^a   Winkles, Jeffrey A ^a,b  

^a HOLLAND LABORATORY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CI 996; CYCLOHEXIMIDE; DACTINOMYCIN; ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR 2; GENISTEIN; GROWTH FACTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; HYPERTENSION; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RESTENOSIS; RNA SYNTHESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0032488543     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7940     Document Type: Article

References (40)

1. Schwartz S. M., Deblois D., O'Brien E. R. M. Circ. Res. 77:1995;445-465.
2. Dzau V. J., Re R. Circulation. 89:1994;493-498.
3. Naftilan A. J., Pratt R. E., Dzau V. J. J. Clin. Invest. 83:1989;1419-1424.
4. Berk B. C., Rao G. N. J. Cell. Physiol. 154:1993;368-380.
5. Stouffer G. A., Shimizu R. T., Turla M. B., Owens G. K. Am. J. Physiol. 264:1993;C390-C395.
6. Weber H., Taylor D. S., Molloy C. J. J. Clin. Invest. 93:1994;788-798.
7. Hahn A. W. A., Resink T. J., Bernhardt J., Ferracin F., Buhler F. R. Biochem. Biophys. Res. Commun. 178:1991;1451-1458.
8. Gibbons G. H., Pratt R. E., Dzau V. J. J. Clin. Invest. 90:1992;456-461.
9. Itoh H., Mukoyama M., Pratt R. E., Gibbons G. H., Dzau V. J. J. Clin. Invest. 91:1993;2268-2274.
10. Koibuchi Y., Lee W. S., Gibbons G. H., Pratt R. E. Hypertension. 21:1993;1046-1050.
11. Temizer D. H., Yoshizumi M., Perrella M. A., Susanni E. E., Quertermous T., Lee M. E. J. Biol. Chem. 267:1992;24892-24896.
12. Delafontaine P., Lou H. J. Biol. Chem. 268:1993;16866-16870.
13. Ali S., Becker M. W., Davis M. G., Dorn G. W. Circ. Res. 75:1994;836-843.
14. Alberts G. F., Hsu D. K. W., Peifley K. A., Winkles J. A. Circ. Res. 75:1994;261-267.
15. Peifley K. A., Alberts G. F., Hsu D. K. W., Feng S. Y., Winkles J. A. Circ. Res. 79:1996;263-270.
16. Burgess W. H., Winkles J. A. Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth. 1996;Oxford Univ. Press, Oxford. p. 154-217.
17. Nabel E. G., Yang Z.-Y., Plautz G., Forough R., Zhan X., Haudenschild C. C., Maciag T., Nabel G. J. Nature. 362:1993;844-846.
18. Cuevas P., Gonzalez A. M., Carceller F., Baird A. Circ. Res. 69:1991;360-369.
19. D'Amore P. A., Smith S. R. Growth Factors. 8:1993;61-75.
20. Lindner V., Lappi D. A., Baird A., Majack R. A., Reidy M. A. Circ. Res. 68:1991;106-113.
21. Goodfriend T. L., Elliott M. E., Catt K. J. N. Engl. J. Med. 334:1996;1649-1654.
22. Keiser J. A., Ryan M. J., Panek R. L., Hodges J. C., Sircar I. J. Pharmacol. Exp. Ther. 272:1995;963-969.
23. Dudley D. T., Panek R. L., Major T. C., Lu G. H., Bruns R. F., Klinkefus B. A., Hodges J. C., Weishaar R. E. Mol. Pharmacol. 38:1990;370-377.
24. Speth R. C., Kim K. H. Biochem. Biophys. Res. Commun. 169:1990;997-1006.
25. Schieffer B., Bernstein K. E., Marrero M. B. J. Mol. Med. 74:1996;85-91.
26. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Biochemistry. 23:1984;5036-5041.
27. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. J. Biol. Chem. 262:1987;5592-5595.
28. Levin E. R. N. Engl. J. Med. 333:1995;356-363.
29. Ohlstein E. H., Elliott J. D., Feuerstein G. Z., Ruffolo R. R. Med. Res. Rev. 16:1996;365-390.
30. Sung C., Arleth A. J., Storer B. L., Ohlstein E. H. J. Pharmacol. Exp. Ther. 271:1994;429-437.
31. Millet D., Desgranges C., Campan M., Gadeau A.-P., Costerousse O. Eur. J. Biochem. 206:1992;367-372.
32. Leduc I., Haddad P., Giasson E., Meloche S. Mol. Pharmacol. 48:1995;582-592.
33. Rubanyi G. M., Polokoff M. A. Pharmacol. Rev. 46:1994;325-415.
34. Douglas S. A., Louden C., Vickery-Clark L. M., Storer B. L., Hart T., Feuerstein G. Z., Elliott J. D., Ohlstein E. H. Circ. Res. 75:1994;190-197.
35. Ferrer P., Valentine M., Jenkins-West T., Weber H., Goller N. L., Durham S. K., Molloy C. J., Moreland S. J. Cardiovasc. Pharmacol. 26:1995;908-915.
36. Hahn A. W. A., Resink T. J., Scott-Burden T., Powell J., Dohi Y., Buhler F. R. Cell Regul. 1:1990;649-659.
37. Le Noble F. A. C., Hekking J. W. M., Van Straaten H. W. M., Slaaf D. W., Struyker Boudier H. A. J. Eur. J. Pharmacol. 195:1991;305-306.
38. Fernandez L. A., Twickler J., Mead A. J. Lab. Clin. Med. 105:1985;141-145.
39. Fishel R. S., Thourani V., Eisenberg S. J., Shai S. Y., Corson M. A., Nabel E. G., Bernstein K. E., Berk B. C. J. Clin. Invest. 95:1995;377-387.
40. Nickenig G., Murphy T. J. Mol. Pharmacol. 46:1994;653-659.